B cells as biomarkers: predicting immune checkpoint therapy adverse events.
about
B cells as biomarkers: predicting immune checkpoint therapy adverse events.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
B cells as biomarkers: predicting immune checkpoint therapy adverse events.
@en
B cells as biomarkers: predicting immune checkpoint therapy adverse events.
@nl
type
label
B cells as biomarkers: predicting immune checkpoint therapy adverse events.
@en
B cells as biomarkers: predicting immune checkpoint therapy adverse events.
@nl
prefLabel
B cells as biomarkers: predicting immune checkpoint therapy adverse events.
@en
B cells as biomarkers: predicting immune checkpoint therapy adverse events.
@nl
P2860
P356
P1476
B cells as biomarkers: predicting immune checkpoint therapy adverse events
@en
P2093
Lisa M Coussens
P2860
P304
P356
10.1172/JCI99036
P407
P577
2018-01-08T00:00:00Z